BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11972300)

  • 1. Effects of 5-campestenone (24-methylcholest-5-en-3-one) on the type 2 diabetes mellitus model animal C57BL/KsJ-db/db mice.
    Suzuki K; Tanaka M; Konno R; Kaneko Y
    Horm Metab Res; 2002 Mar; 34(3):121-6. PubMed ID: 11972300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 5-Campestenone (24-methylcholest-5-en-3-one) on Zucker diabetic fatty rats as a type 2 diabetes mellitus model.
    Konno R; Kaneko Y; Suzuki K; Matsui Y
    Horm Metab Res; 2005 Feb; 37(2):79-83. PubMed ID: 15778923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.
    Arakawa K; Ishihara T; Oku A; Nawano M; Ueta K; Kitamura K; Matsumoto M; Saito A
    Br J Pharmacol; 2001 Jan; 132(2):578-86. PubMed ID: 11159708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the novel oral antidiabetic agent HQL-975 on glucose and lipid metabolism in diabetic db/db mice.
    Ishikawa Y; Watanabe K; Takeno H; Tani T
    Arzneimittelforschung; 1998 Mar; 48(3):245-50. PubMed ID: 9553681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemic and hypolipidemic action of Du-zhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice.
    Park SA; Choi MS; Kim MJ; Jung UJ; Kim HJ; Park KK; Noh HJ; Park HM; Park YB; Lee JS; Lee MK
    J Ethnopharmacol; 2006 Oct; 107(3):412-7. PubMed ID: 16684593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-diabetic effects of ethanol extract from two variants of Artemisia princeps Pampanini in C57BL/KsJ-db/db mice.
    Jung UJ; Baek NI; Chung HG; Bang MH; Yoo JS; Jeong TS; Lee KT; Kang YJ; Lee MK; Kim HJ; Yeo JY; Choi MS
    Food Chem Toxicol; 2007 Oct; 45(10):2022-9. PubMed ID: 17574717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary supplementation with cacao liquor proanthocyanidins prevents elevation of blood glucose levels in diabetic obese mice.
    Tomaru M; Takano H; Osakabe N; Yasuda A; Inoue K; Yanagisawa R; Ohwatari T; Uematsu H
    Nutrition; 2007 Apr; 23(4):351-5. PubMed ID: 17350804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.
    Minoura H; Takeshita S; Ita M; Hirosumi J; Mabuchi M; Kawamura I; Nakajima S; Nakayama O; Kayakiri H; Oku T; Ohkubo-Suzuki A; Fukagawa M; Kojo H; Hanioka K; Yamasaki N; Imoto T; Kobayashi Y; Mutoh S
    Eur J Pharmacol; 2004 Jun; 494(2-3):273-81. PubMed ID: 15212984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.
    Roy S; Khanna V; Mittra S; Dhar A; Singh S; Mahajan DC; Priyadarsiny P; Davis JA; Sattigeri J; Saini KS; Bansal VS
    Life Sci; 2007 Jun; 81(1):72-9. PubMed ID: 17532347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the progression of type 2 diabetes in the C57BL/6J mouse model by an anti-diabetes herbal formula.
    Winters WD; Huo YS; Yao DL
    Phytother Res; 2003 Jun; 17(6):591-8. PubMed ID: 12820223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes.
    Yun SI; Park HO; Kang JH
    J Appl Microbiol; 2009 Nov; 107(5):1681-6. PubMed ID: 19457033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones.
    Kees KL; Fitzgerald JJ; Steiner KE; Mattes JF; Mihan B; Tosi T; Mondoro D; McCaleb ML
    J Med Chem; 1996 Sep; 39(20):3920-8. PubMed ID: 8831758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrangea dulcis folium preserves beta-cell mass in diabetic db/db mice.
    Kim MJ; Leem KH; Kim HK
    Food Chem Toxicol; 2009 Jul; 47(7):1685-8. PubMed ID: 19394398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice.
    Kim SH; Hyun SH; Choung SY
    J Ethnopharmacol; 2006 Mar; 104(1-2):119-23. PubMed ID: 16213119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of type 2 diabetes in mice by products of malaria parasites: I. Effect of inactivated parasites.
    Elased KM; de Souza JB; Playfair JH
    Metabolism; 2000 Jul; 49(7):937-41. PubMed ID: 10910007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition.
    Nagakura T; Yasuda N; Yamazaki K; Ikuta H; Tanaka I
    Metabolism; 2003 Jan; 52(1):81-6. PubMed ID: 12524666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
    Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db/db mice.
    Youn YS; Jeon JE; Chae SY; Lee S; Lee KC
    Diabetes Obes Metab; 2008 Apr; 10(4):343-6. PubMed ID: 18034839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.